Knockdown of PTEN decreases expression of estrogen receptor β and tamoxifen sensitivity of human breast cancer cells
Authors:
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian CancerPLOS ONE, 2012
- Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivityBreast Cancer Research, 2011
- Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cellsBreast Cancer Research and Treatment, 2009
- Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen TherapyJournal of Clinical Oncology, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Why is PTEN an important tumor suppressor?Journal of Cellular Biochemistry, 2007
- Effects of exon-deleted estrogen receptor β transcript variants on growth, apoptosis and gene expression of human breast cancer cell linesBreast Cancer Research and Treatment, 2007
- The changes of estrogen receptor-β variants expression in breast carcinogenesis: Decrease of estrogen receptor-β2 expression is the key event in breast cancer developmentJournal of Surgical Oncology, 2006
- Expression of estrogen receptor β in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosisFEBS Letters, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001